4d Molecular Therapeutics, Inc.
FDMT
Revenue
5.00k
▼-23.00k▼-82.14%
3 Months ChangeAssets
620.12M
▼-9.77M▼-1.55%
3 Months ChangeLiabilities
31.78M
▲2.45M▲8.37%
3 Months ChangeFree Cash Flow
-29.80M
▼-880.00k▼-3.04%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-18
Form 8-K
ID: 0001193125-24-221375
2024-08-08
Form 10-Q
ID: 0000950170-24-094010
2024-08-08
Form 8-K
ID: 0000950170-24-093992
2024-07-23
Form 8-K
ID: 0001193125-24-182544
2024-07-17
Form 8-K
ID: 0001193125-24-179950
2024-06-07
Form 8-K
ID: 0001193125-24-157521
2024-05-24
Form 8-K
ID: 0001193125-24-147093
2024-05-09
Form 8-K
ID: 0000950170-24-057035
2024-05-09
Form 10-Q
ID: 0000950170-24-056933
2024-02-29
Form 8-K
ID: 0000950170-24-023088